Literature DB >> 27550302

Kidney disease in primary anti-phospholipid antibody syndrome.

Borja Gracia-Tello1, David Isenberg2.   

Abstract

APS is an autoimmune disease defined by the presence of arterial or venous thrombotic events and/or pregnancy morbidity in patients who test positive for aPL. APS can be isolated (primary APS) or associated with other autoimmune diseases. The kidney is a major target organ in APS, and renal thrombosis can occur at any level within the vasculature of the kidney (renal arteries, intrarenal vasculature and renal veins). Histological findings vary widely, including ischaemic glomeruli and thrombotic lesions without glomerular or arterial immune deposits on immunofluorescence. Renal involvement in patients with definite APS is treated with long-term anticoagulants as warfarin, but new treatments are being tried. The aim of this article is to review the links between primary APS and kidney disease.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  anti-phospholipid antibodies; anti-phospholipid–associated nephropathy; kidney disease; primary anti-phospholipid syndrome; thrombosis; treatment

Mesh:

Substances:

Year:  2017        PMID: 27550302     DOI: 10.1093/rheumatology/kew307

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  4 in total

1.  Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.

Authors:  Shigeto Horita; Takeshi Zoshima; Satoshi Hara; Makoto Koichi; Sun Hirayama; Kazuyuki Suzuki; Akikatsu Nakashima; Mitsuhiro Kawano
Journal:  CEN Case Rep       Date:  2021-02-17

2.  Kidney involvement in antiphospholipid syndrome - current diagnostic and management problems.

Authors:  Maria Majdan
Journal:  Reumatologia       Date:  2017-10-28

Review 3.  Renal Involvement in Antiphospholipid Syndrome.

Authors:  Alonso Turrent-Carriles; Juan Pablo Herrera-Félix; Mary-Carmen Amigo
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

Review 4.  A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome.

Authors:  Binit Vaidya; Shweta Nakarmi; Rakshya Joshi; Rikesh Baral
Journal:  JNMA J Nepal Med Assoc       Date:  2019 Mar-Apr       Impact factor: 0.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.